Splenic Marginal Zone Lymphoma With Histological Transformation to Hodgkin?s Lymphoma

被引:2
|
作者
Veeraballi, Sindhusha [1 ]
Mirza, Noreen [1 ]
Khawar, Zaineb [2 ]
Shaaban, Hamid [3 ]
机构
[1] St Michaels Hosp, Internal Med, Newark, NJ 19403 USA
[2] St Georges Univ, Sch Med, Internal Med, Newark, NJ USA
[3] St Michaels Hosp, Hematol Oncol, Newark, NJ USA
关键词
nodular subtype hodgkin' s lymphoma; cancer prognosis; tumor transformation; hodgkin's lymphoma; marginal zone lymphoma;
D O I
10.7759/cureus.26738
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Marginal zone lymphoma (MZL) is a rare, slow-growing/indolent B cell lymphoid neoplasm accounting for 10.5% to 11.8% of all B cell lymphomas. MZL originates from the mature B lymphocytes, which are usually present in the marginal zone of the lymphoid follicle. Histological transformation (HT) is defined as sheets of large cells arising in an indolent lymphoma with morphological and immunophenotypic changes suggestive of a high-grade lymphoma such as Hodgkin's lymphoma, diffuse large B cell lymphoma (DLBCL), or Burkitt lymphoma. The median time of transformation ranges from one year to 15 years following the initial diagnosis of MZL. Studies reported that the deletion of TP53 and 7q and mutations in NOTCH2 are commonly associated with HT in MZL. This case report outlines the rare happening of an MZL transformation into a nodular subtype of Hodgkin's lymphoma in a 56-year-old female, which prompted further investigations and a different therapeutic approach. By reporting this case, we emphasize that HT changes the natural history and significantly affects the overall survival of patients with MZL. Hence, it is necessary to get a core needle or excisional biopsy whenever there is a clinical suspicion of HT in MZL for early diagnosis and a better therapeutic approach.
引用
收藏
页数:3
相关论文
共 50 条
  • [21] A CASE WITH SPLENIC MARGINAL ZONE LYMPHOMA
    Cagliyan, G. Akgun
    LEUKEMIA RESEARCH, 2016, 49 : S34 - S34
  • [22] Treatment of splenic marginal zone lymphoma
    Kalpadakis, Christina
    Pangalis, Gerassimos A.
    Angelopoulou, Maria K.
    Vassilakopoulos, Theodoros P.
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2017, 30 (1-2) : 139 - 148
  • [23] Splenic marginal zone lymphoma - Response
    Dierlamm, J
    Pittaluga, S
    Wlodarska, I
    Michaux, L
    Mecucci, C
    DeWolfPeeters, C
    VandenBerghe, H
    BLOOD, 1996, 88 (02) : 751 - 752
  • [24] SPLENIC MARGINAL ZONE LYMPHOMA: CLINICAL-BIOLOGICAL CHARACTERISTICS AND ITS PROGNOSTIC IMPACT ON THE HISTOLOGICAL TRANSFORMATION
    Bastidas Mora, G.
    Lopez Guillermo, A.
    Matutes Juan, E.
    Gine Soca, E.
    Delgado Gonzalez, J.
    Rivas Delgado, A.
    Villamor Casas, N.
    Aymerich Gregorio, M.
    Rozman Jurado, M.
    Campo Guerri, E.
    Magnano, L.
    Martinez Hernandez, D.
    Bea Bobet, S.
    Navarro Lopez, A.
    Baptista, M. J.
    Ramon Planell, O.
    Escoda Teigell, M. L.
    Las Heras Manso, G.
    Font Ferre, L.
    Forcada Guiu, P.
    Vicente Folch, L.
    Balague Ponz, O.
    Costa Bordes, D.
    Colomer Pujol, D.
    Lopez Guerra, M.
    HAEMATOLOGICA, 2018, 103 : 65 - 66
  • [25] Gene expression profiling analysis in splenic marginal zone lymphoma allows to predict survival and histological transformation
    Thieblemont, C
    Ballester, B
    Nasser, V
    Gazzo, S
    Doucet, G
    Felman, P
    Callet-Bauchu, E
    Berger, F
    Loi, L
    Salles, G
    Birnbaum, D
    Coiffier, B
    Houlgatte, R
    BLOOD, 2004, 104 (11) : 319A - 319A
  • [26] Validation of the simplified prognostic score for splenic marginal zone lymphoma of the Splenic Marginal Zone Lymphoma Working Group
    Kalpadakis, Christina
    Pangalis, Gerassimos A.
    Angelopoulou, Maria K.
    Sachanas, Sotirios
    Kontopidou, Flora
    Moschogiannis, Maria
    Ximeri, Maria
    Tsirkinidis, Pantelis
    Yiakoumis, Xanthi
    Papadaki, Helen A.
    Vassilakopoulos, Theodoros P.
    LEUKEMIA & LYMPHOMA, 2014, 55 (11) : 2640 - 2642
  • [27] Follicular lymphoma with involvement of the splenic marginal zone: A pitfall in the differential diagnosis of splenic marginal zone cell lymphoma
    Alkan, S
    Ross, CW
    Hanson, CA
    Schnitzer, B
    HUMAN PATHOLOGY, 1996, 27 (05) : 503 - 506
  • [28] Blastic transformation of splenic marginal zone B-cell lymphoma
    Cualing, H
    Steele, P
    Zellner, D
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2000, 124 (05) : 748 - 752
  • [29] Splenic lymphoma with circulating villous lymphocytes splenic marginal-zone lymphoma
    Catovsky, D
    Matutes, E
    SEMINARS IN HEMATOLOGY, 1999, 36 (02) : 148 - 154
  • [30] Comparison of immunohistochemical staining of splenic marginal zone hyperplasia and splenic marginal zone lymphoma
    Fillman, EP
    Burton, MP
    Ehsan, A
    Neuhauser, TS
    LABORATORY INVESTIGATION, 2003, 83 (01) : 232A - 232A